INTERNATIONAL BIOTECHNOLOGY TRU (IBT.L) Financials
IBT.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-08-31 | 30.5 billion | 3.5 billion |
| 2023-05-31 | 30.5 billion | 3.5 billion |
| 2023-02-28 | 33.1 billion | 3.6 billion |
| 2022-11-30 | 33.1 billion | 3.6 billion |
IBT.L Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-08-31 | 286.4 million | ? |
| 2023-05-31 | 286.4 million | ? |
| 2023-02-28 | 1.1 billion | ? |
| 2022-11-30 | 1.1 billion | ? |
IBT.L Net Income
| Date | Net Income |
|---|---|
| 2023-08-31 | -507.4 million |
| 2023-05-31 | -507.4 million |
| 2023-02-28 | 848.0 million |
| 2022-11-30 | 848.0 million |
IBT.L Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-08-31 | - | - | - |
| 2023-05-31 | - | - | - |
| 2023-02-28 | - | - | - |
| 2022-11-30 | - | - | - |
IBT.L Shares Outstanding
IBT.L Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-08-31 | - | - | 107.6 million | - |
| 2023-05-31 | - | - | 107.6 million | - |
| 2023-02-28 | - | - | 86.6 million | - |
| 2022-11-30 | - | - | 86.5 million | - |
IBT.L Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-08-31 | -413.6 million | - |
| 2023-05-31 | -413.6 million | - |
| 2023-02-28 | 937.0 million | - |
| 2022-11-30 | 937.0 million | - |
IBT.L
Price: £6.40
Dividend Yield: 0.00%
Forward Dividend Yield: 4.33%
Payout Ratio: 16352.94%
Dividend Per Share: 27.80 GBp
Earnings Per Share: 0.17 GBp
P/E Ratio: 39.06
Exchange: LSE
Sector: Financial Services
Industry: Asset Management
Volume: 69621
Market Capitalization: 242.1 million
Average Dividend Frequency: 2
Years Paying Dividends: 7
DGR3: 3.36%
DGR5: 0.15%